BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Asia
BioWorld Asia
July 27, 2005
View Archived Issues
Abingworth's Fund For Public Firms Has $53M First Closing
LONDON - The venture capital firm Abingworth Management announced the first closing at $53 million of a new fund dedicated for quoted companies. (BioWorld International)
Read More
Havana Congress Celebrates Cuba's Biotech Achievements
Read More
Immunological Study Hopes To Boost Cervical Cancer Vaccine
Read More
Protalix Series C: $5.3M For Gaucher's Disease Product
Read More
NovaThera Raises £2.75M, Signs Bioglass Agreements
Read More
Other News To Note
Read More